Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a Locations section listing Delaware and District of Columbia as study sites. The page also removes the separate Delaware Locations and District of Columbia Locations entries and updates the revision to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:25:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no visible changes to study details or layout. This appears to be a metadata/versioning update rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T20:54:17.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    General site status/funding notice was removed from the page. The core trial information and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:13:13.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The screenshots show only minor UI refresh and updated timestamps; no changes to core study content such as objectives, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:48:17.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:39:25.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:54:17.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.